MedTrace Logo

Study of the Physiology of Pre-eclampsia and Vascular IUGR With Constitution of a Biological Collection

NCT03626233 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2022-12-21

No results posted yet for this study

Summary

Preeclampsia and intrauterine growth retardation (IUGR) are serious and frequent pathologies, specific to pregnancy. They represent 70 000 new cases a year, or 9% of pregnancies and cause 50,000 premature births per year in France. The consequences in terms of morbidity and perinatal morbidity and the medical and economic costs make it an issue public health. Pre-eclampsia associates maternal hypertension with dysfunction kidney. There is no cure for pre-eclampsia or IUGR vascular during pregnancy. These pathologies invariably evolve towards a maternal and / or fetal aggravation sometimes very fast. Primary prevention and secondary education and screening for these pathologies are still insufficient. A better understanding of the pathophysiology of these placental vascular pathologies is necessary for the development of supported medical, obstetric and pediatric that will improve the state of health maternal and neonatal

Conditions

  • Pre-Eclampsia

Interventions

OTHER

collect of placenta, blood and urinary samples at delivery

collect of placenta, blood and urinary samples at delivery

Sponsors & Collaborators

  • Centre Hospitalier Intercommunal Creteil

    lead OTHER

Principal Investigators

  • Edouard Lecarpentier, MD PhD · CHI CRETEIL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-06
Primary Completion
2023-08-31
Completion
2024-04-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03626233 on ClinicalTrials.gov